Vaqta Paediatric

Vaqta Paediatric is an inactivated Hepatitis A vaccine designed to protect children against Hepatitis A virus. It is produced using human diploid (MRC-5) fibroblast cells. This vaccine helps stimulate immunity in paediatric patients.

Vaqta Paediatric is used to provide immunity against Hepatitis A virus in children. It is indicated for active immunisation of paediatric patients aged 12 months and older. The vaccine helps protect against infection caused by the Hepatitis A virus. Parents often ask, what is Vaqta Paediatric used for in children.

After administration, Vaqta Paediatric works by stimulating the immune system to produce antibodies against the Hepatitis A virus. This immune response helps provide protection against future exposure to the virus. Common effects include mild soreness or redness at the injection site.

Vaqta Paediatric should be handled with care, following standard vaccine storage and administration guidelines. It is important to ensure the vaccine is kept refrigerated and administered by a healthcare professional. Patients with known allergies to any component of the vaccine should avoid its use.

Vaqta Paediatric may interact with immunosuppressive therapies, potentially reducing its effectiveness. Concurrent use of other vaccines should be evaluated by a healthcare provider to avoid potential interactions. Alcohol or other substances do not directly interact with the vaccine but may affect general health.